Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial
Ashley M. Nelson(Harvard University), Thomas W. LeBlanc(Duke University), Jennifer S. Temel(Massachusetts General Hospital), Amir T. Fathi(University of Southern California), Hermioni L. Amonoo(Dana-Farber Cancer Institute), Alison R. Kavanaugh(Harvard University), Jason A. Webb(Oregon Health & Science University), Joseph A. Greer(Harvard University), Areej El‐Jawahri(Massachusetts General Hospital), Mitchell W. Lavoie(University of Massachusetts Chan Medical School), Julia Rice(Massachusetts General Hospital), Vicki A. Jackson(Johns Hopkins University), Andrew M. Brunner(Harvard University)
Cited by 30
Related Papers
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial
|Journal of Clinical Oncology|2017|834
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655